- Home
- PACB vs AMRN Comparison
PACB vs AMRN Comparison
Compare PACB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- AMRN
- Stock Information
- Founded
- PACB 2000
- AMRN 1989
- Country
- PACB United States
- AMRN Ireland
- Employees
- PACB N/A
- AMRN N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- AMRN Health Care
- Exchange
- PACB Nasdaq
- AMRN Nasdaq
- Market Cap
- PACB 369.5M
- AMRN 302.0M
- IPO Year
- PACB 2010
- AMRN 1993
- Fundamental
- Price
- PACB $1.94
- AMRN $16.40
- Analyst Decision
- PACB Buy
- AMRN Strong Sell
- Analyst Count
- PACB 7
- AMRN 1
- Target Price
- PACB $1.90
- AMRN $12.00
- AVG Volume (30 Days)
- PACB 9.7M
- AMRN 161.7K
- Earning Date
- PACB 11-05-2025
- AMRN 10-29-2025
- Dividend Yield
- PACB N/A
- AMRN N/A
- EPS Growth
- PACB N/A
- AMRN N/A
- EPS
- PACB N/A
- AMRN N/A
- Revenue
- PACB $156,110,000.00
- AMRN $226,733,000.00
- Revenue This Year
- PACB $6.06
- AMRN N/A
- Revenue Next Year
- PACB $15.15
- AMRN N/A
- P/E Ratio
- PACB N/A
- AMRN N/A
- Revenue Growth
- PACB N/A
- AMRN N/A
- 52 Week Low
- PACB $0.85
- AMRN $7.08
- 52 Week High
- PACB $2.72
- AMRN $20.90
- Technical
- Relative Strength Index (RSI)
- PACB 60.27
- AMRN 35.90
- Support Level
- PACB $1.93
- AMRN $19.39
- Resistance Level
- PACB $2.01
- AMRN $20.90
- Average True Range (ATR)
- PACB 0.15
- AMRN 1.04
- MACD
- PACB 0.02
- AMRN -0.46
- Stochastic Oscillator
- PACB 73.24
- AMRN 4.66
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.